Neuland Laboratories has reported results for the second quarter ended September 30, 2013.
The company has reported 11.68% rise in its net profit at Rs 3.44 crore for the quarter as compared to Rs 3.08 crore for the same quarter in the previous year. However, total income from operation of the company has decreased by 10.97% at Rs 105.09 crore for quarter under review as compared to Rs 118.04 crore for the quarter ended September 30, 2012.
Neuland Laboratories is engaged in manufacturing of Salbutamol Sulphate. The company has has two world-class API manufacturing facilities close to the city of Hyderabad, capable in handling complex and hazardous reactions.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1847.30 |
| Dr. Reddys Lab | 1293.25 |
| Cipla | 1347.70 |
| Zydus Lifesciences | 938.90 |
| Lupin | 2377.90 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: